Breaking

Drug Watch

AI and New Strategies Combat Rising Antibiotic Resistance
Drug Watch

AI and New Strategies Combat Rising Antibiotic Resistance

AI and new strategies are helping combat rising antibiotic resistance by analyzing genetic data to track superbugs and develop novel treatments.

Zenobia Fairweather · November 18, 2026
Canada’s Therapy Innovations Face Patient Access Hurdles
Drug Watch

Canada’s Therapy Innovations Face Patient Access Hurdles

Canada's therapy innovations face patient access hurdles, as a gap between scientific breakthroughs and healthcare coverage persists.

Zenobia Fairweather · November 17, 2026
AI models detect pain details missed by standard medical scores
Drug Watch

AI models detect pain details missed by standard medical scores

Large language models are being tested to capture chronic pain details missed by standard medical scores, according to a study published October…

Florinda Ashbridge · November 13, 2026
FDA approves new hepatitis B treatment
Drug Watch

FDA approves new hepatitis B treatment

FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.

Zenobia Fairweather · November 4, 2026
FDA Approves Tildrakizumab for Psoriatic Arthritis
Drug Watch

FDA Approves Tildrakizumab for Psoriatic Arthritis

The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.

Zenobia Fairweather · November 3, 2026
AI Models Often Give Wrong Medication Doses
Drug Watch

AI Models Often Give Wrong Medication Doses

AI models give wrong medication doses in about 2% of cases, Doximity research finds, raising concerns about AI in healthcare.

Zenobia Fairweather · November 1, 2026
UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift
Drug Watch

UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift

UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift.

Florinda Ashbridge · October 30, 2026
U.S. Census Changes Pose Serious Threat to Public Health” “U.S.
Drug Watch

U.S. Census Changes Pose Serious Threat to Public Health” “U.S.

Proposed U.S. Census changes may seriously threaten public health by impacting health research and federal programs.

Florinda Ashbridge · October 10, 2026
Subcutaneous Efgartigimod Improves Ocular Myasthenia Symptoms
Drug Watch

Subcutaneous Efgartigimod Improves Ocular Myasthenia Symptoms

Subcutaneous efgartigimod significantly improves ocular myasthenia symptoms, with III ADAPT OCULUS data showing less double vision and drooping eyelids.

Florinda Ashbridge · October 5, 2026
New device treats Meibomian gland dysfunction
Drug Watch

New device treats Meibomian gland dysfunction

Meibomian gland dysfunction treatment may be improved with new device Meiboleyes, designed to address drawbacks of existing tools.

Zenobia Fairweather · September 28, 2026